RooLife : Change of Director Interest Notices x 4

Appendix 3Y Change of Director's Interest Notice

Appendix 3Y

Rule 3.19A.2

For personal use only

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	RooLife Group Ltd
ABN	14 613 410 398

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Warren Barry
Date of last notice	1 November 2021

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Indirect interest
Nature of indirect interest	Barry Consulting Pty Ltd ATF Barry Family Trust
(including registered holder)	(Mr Barry is a beneficiary of this trust)
Note: Provide details of the circumstances giving rise to the
relevant interest.	Barry Family Super Fund (Mr Barry is a member
	of the Fund)
Date of change	2 December 2021

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1

Appendix 3Y

Change of Director's Interest Notice

		No. of securities held prior to change	25,325,267 Fully Paid Ordinary Shares.
only			8,000,000 Executive Officer Options expiring 5 February
		2024	with an exercise price of $0.055 subject to the
			$0.055 per share.
			following vesting conditions:
			-	2,400,000: Vesting Condition will be taken to have
				been met if, for any consecutive trading day period
				between the date of the grant of the Executive
				Officer Options and 5 February 2021, the VWAP of
				the Company's Shares is equal to or greater than
use			-	2,400,000: Vesting Condition will be taken to have
			been met if, for any consecutive trading day period
			between the date of the grant of the Executive
			Officer Options and 5 February 2022, the VWAP of
			the Company's Shares is equal to or greater than
			$0.08 per share.
		-	3,200,000: Vesting Condition will be taken to have
personal				been met if, for any consecutive trading day period
			between the date of the grant of the Executive
			Officer Options and 5 February 2023, the VWAP of
				the Company's Shares is equal to or greater than
				$0.12 per share.
			-	All Executive Officer Options also have a time-based
				vesting condition of 5 February 2023
		Class	Performance Rights - (Issued)
			Unlisted Options - (Cancelled)
		Number acquired	13,500,000
		Number disposed	8,000,000
		Value/Consideration	Nil. Performance Rights Issued pursuant to shareholder
		Note: If consideration is non-cash, provide details and estimated	approval. Unlisted Options cancelled upon issue of
		valuation	Performance Rights
For
	No. of securities held after change	25,325,267 Fully Paid Ordinary Shares.
		13,500,000 Performance Rights subject to vesting
			conditions as set out in the Notice of Meeting lodged
			with the ASX on 28 October 2021, expiring on 1
			December 2024.
		Nature of change
		Example: on-market trade, off-market trade, exercise of options,	Performance Rights Issued pursuant to shareholder
		issue of securities under dividend reinvestment plan, participation
		in buy-back	approval. Unlisted Options cancelled upon issue of
			Performance Rights
	+ See chapter 19 for defined terms.
	Appendix 3Y Page 2		01/01/2011

For personal use only

Appendix 3Y

Change of Director's Interest Notice

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to which interest	N/A
related prior to change
Note: Details are only required for a contract in relation to which
the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details and an estimated
valuation
Interest after change	N/A
Part 3 - +Closed period
Were the interests in the securities or contracts detailed above traded during a	No
+closed period where prior written clearance was required?
If so, was prior written clearance provided to allow the trade to proceed during	N/A
this period?
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director's Interest Notice

Appendix 3Y

Rule 3.19A.2

For personal use only

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	RooLife Group Ltd
ABN	14 613 410 398

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Bryan Carr
Date of last notice	1 November 2021

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Indirect interest
Nature of indirect interest	Bryan Edward Carr ATF Shabaz Family Trust (Mr
(including registered holder)	Carr is a beneficiary of this trust)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Date of change	2 December 2021

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1

Appendix 3Y

Change of Director's Interest Notice

	No. of securities held prior to change	12,750,000 Fully Paid Ordinary Shares.
only		12,000,000 Executive Officer Options expiring 5 February
		2024 with an exercise price of $0.055 subject to
		$0.055 per share.
			the following vesting conditions:
		-	3,600,000: Vesting Condition will be taken to have
			been met if, for any consecutive trading day period
			between the date of the grant of the Executive
			Officer Options and 5 February 2021, the VWAP of
			the Company's Shares is equal to or greater than
use		-	3,600,000: Vesting Condition will be taken to have
	-
		been met if, for any consecutive trading day period
		between the date of the grant of the Executive
		Officer Options and 5 February 2022, the VWAP of
		the Company's Shares is equal to or greater than
	-	$0.08 per share.
	-	4,800,000: Vesting Condition will be taken to have
personal			been met if, for any consecutive trading day period
		between the date of the grant of the Executive
		Officer Options and 5 February 2023, the VWAP of
			the Company's Shares is equal to or greater than
			$0.12 per share.
		All Executive Officer Options also have a time-based
		vesting condition of 5 February 2023.
	Class	Performance Rights - (Issued)
		Unlisted Options - (Cancelled)
	Number acquired	22,500,000
	Number disposed	12,000,000
	Value/Consideration	Nil. Performance Rights Issued pursuant to shareholder
	Note: If consideration is non-cash, provide details and estimated	approval. Unlisted Options cancelled upon issue of
	valuation	Performance Rights
For	No. of securities held after change	12,750,000 Fully Paid Ordinary Shares.
	22,500,000 Performance Rights subject to vesting
		conditions as set out in the Notice of Meeting lodged
		with the ASX on 28 October 2021, expiring on 1
		December 2024.
	Nature of change
	Example: on-market trade, off-market trade, exercise of options,	Performance Rights Issued pursuant to shareholder
	issue of securities under dividend reinvestment plan, participation
	in buy-back	approval. Unlisted Options cancelled upon issue of
		Performance Rights

+ See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011